Medical Monitoring Project Facility Survey (paper)

Medical Monitoring Project Facility Survey

Att 4 MMP facility survey instrument final_revised 11.20.2020

OMB: 0920-1340

Document [docx]
Download: docx | pdf

Shape193 Shape194 Survey ID

Form Approved

OMB No.: 0920-New

Expiration date: XX/XX/XXXX





Medical Monitoring Project Facility Survey





Attachment 4

MMP Facility Survey

















Public reporting burden of this collection of information is estimated to average 30 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; Attn: OMB-PRA (0920-New)



General instructions

  1. Your health care facility was selected to receive the Centers for Disease Control and Prevention (CDC) Medical Monitoring Project (MMP) HIV facility survey because 1 or more patients with HIV have received care at your facility.

  2. Who should complete the survey?  The survey should be completed by a senior facility administrator, nurse manager, and/or clinical director. If preferred, that person may call [insert name of CDC contractor] to provide their responses over the phone (xxx-xxx-xxxx).

  3. Survey questions refer to characteristics of the facility providing HIV care at the location named in the survey invitation.

    1. Survey questions refer to characteristics of the facility during the past 12 months, unless otherwise specified.

    2. The term provider refers to a health care professional with prescribing privileges authorized by the state.

  4. Do not include information that would identify the facility, e.g. name of facility, your name, or names of anyone who works at the facility. Survey data will only be associated with a facility ID number.





I. GENERAL CHARACTERISTICS

Shape1 Facility ID code:



Shape3 Shape2 11-digit FIPS code:












Which terms describe the facility? (Choose all that apply.)

Shape4

1 Federally qualified Health Center (FQHC): Search

Shape5

2 FQHC look-alike: Definition

Shape6

3 Hospital-based (infectious disease clinic)

4 Hospital-based (primary care clinic)

5 Private practice

6 State or local health department

Shape7

7 Veterans Administration

Shape8

8 STD clinic

Shape10

Shape9 9 Research

10 Other community-based organization

Shape11 11 Correctional facility

Shape12 12 Indian Health Service, Tribal Health, or Urban Indian Health Center

Shape13 13 Other, specify: ______________


Does the facility receive Ryan White HIV/AIDS Program funding?

Shape14

1 No

Shape15 Yes 2 Yes, choose all that apply below


Shape16

1 Part A

2 Part B

3 Part C

4 Part D

5 Part F (if not checked, skip to next question)

Shape17

1 SPNS

Shape18

2 AETC

Shape19

3 Dental

Shape20

4 MAI



Which types of health coverage does the facility accept? (Choose all that apply.)

Shape21 1 Medicaid, including Medicaid managed care

2 Medicare, including Medicare Advantage

3 Private insurance

4 ADAP or other Ryan White coverage

Shape22 5 Veterans Administration

Shape23 Shape24

6 Tricare

7 Other, specify: ______________

Shape25 8 None of the above




Does the facility use a sliding fee scale for patients without health coverage, i.e., fees adjusted based on ability to pay?

Shape26

1 No

Shape27 Yes 2 Yes



Shape28 Number of individual HIV care providers (full-time or part-time)

Shape29

1 Physicians (MD or DO)

2 Nurse practitioners

3 Other advance practice nurses (e.g., nurse specialist, midwife, anesthetist)

4 Physician assistants

5 Registered pharmacists (with prescribing privileges)

6 Other, specify: ___________



Is there normally a physician at the facility at least 5 days per week who can provide HIV care (not necessarily the same individual each day)?

Shape30

1 No

Shape31 Yes 2 Yes



Does the facility have:

Shape32 1 Only full-time HIV care providers

2 A mix of full-time and part-time HIV care providers

3Only part-time HIV care providers


What physician specialties practice at the same geographic location as the facility (onsite)? (Choose all that apply.)

Shape33 1 Infectious disease

Shape34 2 Internal medicine

Shape35 3 Family medicine

Shape36 4 Other general practice

Shape37 5 Hematology/oncology

Shape38 Shape39

6 Neurology

7 Dermatology

Shape40 8 Pulmonary

Shape41 9 Obstetrics and gynecology

Shape42 10 Cardiology

Shape43 11 Psychiatry

Shape44 11 12 Ophthalmology

Shape45

12 13 Other, specify: _______________



Number of patients for whom the facility has provided HIV care during the past year, defined as having an HIV viral load or CD4 count ordered or being prescribed antiretroviral therapy for treatment of HIV. Consider running a report of HIV ICD-9/10 codes.

Shape46



Does the facility provide medical care for people who do not have HIV?

Shape47

1 No (Skip next 2 questions)

Shape48 Yes 2 Yes



Does the facility provide HIV pre-exposure prophylaxis (PrEP)?

Shape49

1 No

Shape50 Yes 2 Yes



Does the facility provide HIV post-exposure prophylaxis (PEP)?

Shape51

1 No

Shape52 Yes 2 Yes



Does the facility provide HIV-specific stigma or discrimination training at least once for all staff who interact with patients.

Shape53

1 No

Shape54 Yes 2 Yes



Does the acility provide training in other areas of cultural competency at least once for all staff who interact with patients?

Shape55 1 No

Shape56 2 Yes, specify: _______________ (Examples)




II. CLINCAL AND SUPPORTIVE SERVICES


Which of these clinical and supportive services are currently available at the same geographic location (onsite) or through established outside referral relationships? (Choose all that apply.)



Onsite

Established outside referral relationship




Clinical case management provided by a nurse

Shape57 1

Shape58 2


Other case management

Shape59 1

Shape60 2


Patient navigation

Shape61 1

Shape62 2


Peer support counseling

Shape63 1

Shape64 2


Peer support groups

Shape65 1

Shape66 2


Access to tools that support ART adherence, such as pill trays or dose reminder apps

Shape67 1

Shape68 2


Social work

Shape69 1

Shape70 2


Language interpretation services

Shape71 1

Shape72 2


Assistance with transportation

Shape73 1

Shape74 2


Assistance with housing

Shape75 1

Shape76 2


Child care

Shape77 1

Shape78 2


Mental health services

Shape79 1

Shape80 2


Substance use disorders treatment

Shape81 1

Shape82 2


Medication-assisted treatment (MAT) for substance use disorders

Shape83 1

Shape84 2


Syringe services

Shape85 1

Shape86 2


Tobacco cessation services

Shape87 1

Shape88 2


Medical nutrition therapy

Shape89 1

Shape90 2


Food bank or meal delivery

Shape91 1

Shape92 2


Pharmacy

Shape93 1

Shape94 2


Dental care

Shape95 1

Shape96 2


High resolution anoscopy

Shape97 1

Shape98 2


Gynecologic care

Shape99 1

Shape100 2


Long-acting contraception (injection or implant)

Shape101 1

Shape102 2


Colposcopy

Shape103 1

Shape104 2


Prenatal care

Shape105 1

Shape106 2


Transgender hormone therapy

Shape107 1

Shape108 2


STI screening and treatment

Shape109 1

Shape110 2


Counseling about reducing risk of HIV and STI transmission

Shape111 1

Shape112 2


HIV testing for partners of HIV patients and others

Shape113 1

Shape114 2


Free home HIV testing for partners of HIV patients and others

Shape115 1

Shape116 2


III. ENROLLMENT AND INITIATION OF ANTIRETROVIRAL THERAPY



Which of these documents are required for scheduling the first appointment with an HIV care provider? (Choose all that apply.)




Proof of income

Shape117 1


Proof of residence

Shape118 1


Government-issued identification

Shape119 1


Result of a test for tuberculosis (PPD or IGRA)

Shape120 1


Positive HIV antibody or detectable viral load

Shape121 1


CD4 lymphocyte count result

Shape122 1


None of the above

Shape123 1



Within how many business days of an initial request are HIV patients who are new to the facility routinely offered an appointment with an HIV care provider?

Shape124



What are the barriers to offering new patients an appointment with an HIV care provider within 1 business day of an initial request? (Choose all that apply.)




Patient preference

Shape125 1


Insufficient provider capacity to see rapid entry patients

Shape126 1


Patients lack documents required for facility enrollment

Shape127 1


Patients lack documents required for Ryan White HIV/AIDS Program enrollment

Shape128 1


Facility administration is not committed to rapid enrollment

Shape129 1


Other staff are not committed to rapid enrollment

Shape130 1


Other, specify: _________________________

Shape131 1



Which of the following patients are routinely able to obtain a 30-day supply of antiretroviral medication on the day of their first visit with an HIV care provider? (Choose all that apply.)




Patients with no prescription coverage, e.g., by using a pharmaceutical patient assistance program or funds designated for this purpose

Shape132 1


Patients without results of baseline laboratory tests

Shape133 1


All patients (If selected, skip next question)

Shape134 1



Which of these are barriers to patients obtaining a 30-day supply of antiretroviral therapy on the day of the first HIV care provider visit? (Choose all that apply.)




Patient preference

Shape135 1


Prescription not given because test results are not available

Shape136 1


Delay getting medication paid for

Shape137 1


Antiretroviral starter packs are not available to be given to patients

Shape138 1


Lack of trained staff to submit patient assistance program applications for free antiretrovirals

Shape139 1


Patient cannot afford copayment

Shape140 1


Providers are not committed to immediate antiretroviral initiation

Shape141 1


Facility administration is not committed to immediate antiretroviral initiation

Shape142 1


Lack of a standardized protocol for all clinicians to follow

Shape143 1


Other, specify: ___________

Shape144 1







IV. HIV TELEHEALTH/TELEMEDICINE



Have any providers received HIV clinical consultation or mentoring from outside providers via remote conferencing, e.g., HIV ECHO ?

Shape145

1 No

Shape146 Yes 2 Yes



Have any providers provided HIV clinical consultation or mentoring for outside providers via remote conferencing, e.g., HIV ECHO ?

Shape147

1 No

Shape148 Yes 2 Yes



Have any patients received HIV clinical care from outside HIV providers via remote conferencing during a visit (in-person or virtual) at your facility?

Shape149

1 No

Shape150 Yes 2 Yes



Have any providers provided HIV clinical care for patients via remote conferencing?

Shape151

1 No

Shape152 Yes 2 Yes




V. SUPPORTING RETENTION IN CARE



Does the facility use data to systematically monitor retention in care of all HIV patients?

Shape153

1 No (skip next question)

Shape154 Yes 2 Yes



Which types of data does the facility use to monitor retention in care? (Choose all that apply.)




Internal data (e.g., electronic health record or billing data)

Shape155 1


Health department surveillance data

Shape156 1


CAREWare

Shape157 1


Pharmacy refill data

Shape158 1


Other, specify:___________________

Shape159 1



Does the facility collaborate with the state or local health department to identify or contact patients who are out of care, e.g., by providing clinic data or contact information to the health department?

Shape160

1 No

Shape161 Yes 2 Yes



Does the facility send patient reminders before all provider appointments?

Shape162

1 No (skip next question)

Shape163 Yes 2 Yes



Which of these patient reminders are routinely used at the facility (?




Text, email, or patient portal message

Shape164 1


Automated phone calls

Shape165 1


Live phone calls

Shape166 1


Letter

Shape167 1



Does the facility follow-up on all missed appointments?

Shape168

1 No (skip next question)

Shape169 Yes 2 Yes



With which methods does the facility follow-up on missed appointments? (Choose all that apply.)




Text, email, or patient portal message

Shape170 1


Automated phone calls

Shape171 1


Live phone calls

Shape172 1


Letter

Shape173 1


Outreach in the field by a facility employee

Shape174 1



Is there a pharmacy at the same geographic location as the facility (onsite)?

Shape175

1 No (skip to COVID section)

Shape176 Yes 2 Yes



Does the facility have direct access to information about prescription fulfillment and pick-up by patients?

Shape177

1 No (skip next 2 questions)

Shape178 Yes 2 Yes



Does the facility notify patients of all missed prescription pickups?

Shape179

1 No (skip next question)

Shape180 Yes 2 Yes



With which methods does the facility notify patients of missed prescription pick-ups?




Text, email, or patient portal message

Shape181 1


Automated phone calls

Shape182 1


Live phone calls

Shape183 1


Letter

Shape184 1




VI. PREVENTION OF PATIENT EXPOSURE TO COVID-19

Which of these measures has your facility taken to protect patients from exposure to COVID-19? (Choose all that apply.)




Screening of all staff and patients for COVID-19 before entering the facility, i.e.,temperature and symptom screening.

Shape185 1


Separation of patients in waiting areas by at least 6 feet.

Shape186 1


Face masks worn at all times by all persons in the facility.

Shape187 1


Telehealth provider visits offered to all patients not requiring face-to-face contact.

Shape188 1


Telehealth visits with other facility staff (e.g., case managers/social workers, mental health staff, financial counselors) offered to all patients not requiring face-to-face contact.

Shape189 1


Home visits for patients requiring face-to-face contact.

Shape190 1


Deferring of routine CD4 and viral load testing.

Shape191 1


Arranging delivery of prescriptions rather than pick-up at the pharmacy

Shape192 1




23


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorWeiser, John (CDC/DDID/NCHHSTP/DHPSE)
File Modified0000-00-00
File Created2021-08-09

© 2024 OMB.report | Privacy Policy